Evidence map›Paper›PMID 23115478›Full record

ArticleBiomarker insights2012

Knowledge building insights on biomarkers of arsenic toxicity to keratinocytes and melanocytes.

Raphael D Isokpehi, Udensi K Udensi, Matthew N Anyanwu, Andreas N Mbah, Matilda O Johnson, Kafui Edusei, Michael A Bauer, Roger A Hall, Omotayo R Awofolu

Open access · goldAbstract read
In one paragraph

Article in Biomarker insights, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Arsenic: A Perspective on Its Effect on Pioglitazone Bioavailability.International journal of environmental research and public health · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Genomic Evidence for Bacterial Determinants Influencing Obesity Development.International journal of environmental research and public health · 2017
    Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Raphael D IsokpehiRCMI Center for Environmental Health, College of Science, Engineering and Technology, Jackson State University, Jackson, MS, USA. ; Center for Bioinformatics & Computational Biology, Department of Biology, Jackson State University, Jackson, MS, USA.
Udensi K Udensi
Matthew N Anyanwu
Andreas N Mbah
Matilda O Johnson
Kafui Edusei
Michael A Bauer
Roger A Hall
Omotayo R Awofolu
Jackson State University · USUniversity of Arkansas at Little Rock · USUniversity of Pretoria · ZAUniversity of Tennessee Health Science Center · US

Funding

Training and Mentoring Core P20GM103476 · NIGMS · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI MICHAEL R GARRETT · 2012 to 2026
$60.2M
VIRULENCE MECHANISMS IN ESCHERICHIA COLIP20RR016460 · NCRR · UNIV OF ARKANSAS FOR MED SCIS · PI HENSLEY, LORI · 2001 to 2011
$33.1M
TOUGALOO PROTEOMICSP20RR016476 · NCRR · UNIVERSITY OF SOUTHERN MISSISSIPPI · PI SHEARER, GLEN · 2001 to 2011
$30.4M
Nation Center- Integrative Biomedical Informatics(RMI)U54DA021519 · NIDA · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI ATHEY, BRIAN DAVID · 2005 to 2010
$21.3M
TRANSCRIPTOMICS OF GIARDIA LAMBLIAG12RR013459 · NCRR · JACKSON STATE UNIVERSITY · PI TCHOUNWOU, PAUL B. · 1998 to 2011
$18.0M
Bioinformatics Programs at Minority InstitutionsT36GM095335 · NIGMS · CARNEGIE-MELLON UNIVERSITY · PI ROPELEWSKI, ALEXANDER J · 2011 to 2015
$3.2M
NCRR NIH HHS G12 RR013459NCRR NIH HHS P20 RR016460NCRR NIH HHS P20 RR016476NIDA NIH HHS U54 DA021519NIGMS NIH HHS P20 GM103476NIGMS NIH HHS T36 GM095335
6 · The paper itself

Abstract

Exposure to inorganic arsenic induces skin cancer and abnormal pigmentation in susceptible humans. High-throughput gene transcription assays such as DNA microarrays allow for the identification of biological pathways affected by arsenic that lead to initiation and progression of skin cancer and abnormal pigmentation. The overall purpose of the reported research was to determine knowledge building insights on biomarker genes for arsenic toxicity to human epidermal cells by integrating a collection of gene lists annotated with biological information. The information sets included toxicogenomics gene-chemical interaction; enzymes encoded in the human genome; enriched biological information associated with genes; environmentally relevant gene sequence variation; and effects of non-synonymous single nucleotide polymorphisms (SNPs) on protein function. Molecular network construction for arsenic upregulated genes TNFSF18 (tumor necrosis factor [ligand] superfamily member 18) and IL1R2 (interleukin 1 Receptor, type 2) revealed subnetwork interconnections to E2F4, an oncogenic transcription factor, predominantly expressed at the onset of keratinocyte differentiation. Visual analytics integration of gene information sources helped identify RAC1, a GTP binding protein, and TFRC, an iron uptake protein as prioritized arsenic-perturbed protein targets for biological processes leading to skin hyperpigmentation. RAC1 regulates the formation of dendrites that transfer melanin from melanocytes to neighboring keratinocytes. Increased melanocyte dendricity is correlated with hyperpigmentation. TFRC is a key determinant of the amount and location of iron in the epidermis. Aberrant TFRC expression could impair cutaneous iron metabolism leading to abnormal pigmentation seen in some humans exposed to arsenicals. The reported findings contribute to insights on how arsenic could impair the function of genes and biological pathways in epidermal cells. Finally, we developed visual analytics resources to facilitate further exploration of the information and knowledge building insights on arsenic toxicity to human epidermal keratinocytes and melanocytes.

Indexed as

arsenicdisulfide bondenvironmental response genesfunctional annotationhyperpigmentationiron uptakekeratinocytemelanocyteRAC1skin cancerSNPsTFRCtoxicogenomicsvicinal cysteines Isokpehi et al

Identifiers

PMID23115478
PMCPMC3480875
OpenAlexW2007042320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.